← Eichor
Study identifier: NCT05686642 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Condition: Acute Ischemic Stroke  ·  Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd

PhasePhase 2
Planned participants300
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This phase II clinical study is designed to evaluate the safety and efficacy of LT3001 in the treatment of acute ischemic stroke

This description comes directly from the study's public registry record.

Talk to the study team

Yongjun Wang  ·  0086-010-59978538  ·  Yongjunwang111@aliyun.com

Always discuss trial participation with your own doctor first.

Locations (28)

Beijing Luhe Hospital Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
The First Affiliated Hospital of Jinan UniversityGuangzhou, Guangdong, ChinaRecruiting
Luoyang Third People's HospitalLuoyang, He'nan, ChinaRecruiting
Harrison International Peace HospitalHengshui, Hebei, ChinaRecruiting
Daqing Oilfield General HospitalDaqing, Heilongjiang, ChinaRecruiting
Zhongnan Hospital of Wuhan UniversityWuhan, Hubei, ChinaRecruiting
The First Affiliated Hospital of Baotou Medical CollegeBaotou, Inner Mongolia, ChinaRecruiting
Inner Mongolia Baogang HospitalBaotou, Inner Mongolia, ChinaRecruiting
Huai'an Second People's HospitalHuai'an, Jiangsu, ChinaRecruiting
The Second Affiliated Hospital of Soochow UniversitySuzhou, Jiangsu, ChinaRecruiting
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou, Jiangsu, ChinaRecruiting
Pingxiang People's HospitalPingxiang, Jiangxi, ChinaRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05686642